Kum Ming Woo

Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA.

BioEcho Life Sciences GmbH is a company based in Cologne, Germany that specializes in nucleic acid sample preparation tools for various applications such as clinical, biotech, life sciences research, agricultural, and industrial. BioEcho's mission is to overcome the limitations of standardized methods in molecular biology and diagnostic workflows by utilizing their proprietary technologies and technical expertise. The German company's kits offer industry-leading quality, speed, simplicity, and sustainability capabilities for the purification of high-quality nucleic acids from a wide variety of samples. The company is ISO 9001 and ISO 13485 certified and has an unwavering dedication to sustainability achieved through a specific focus on socially responsible behavior and the development of environmentally friendly products. The company was founded in 2016 by Markus Müller and Frank Schäfer, who have been the CEOs since then.

Biolog, Inc. enages in the manufacture of diagnostic substances. It offers microbial identification, phenotype microarrays for microbial and mammalian cells, mitochondria function assays, educational porta, microbiome, microbial community analysis, and microbial detection. The company was founded by Barry R. Bochner and Donald W. Barnby in 1984 and is headquartered in Hayward, CA.

Weber & Associates, Inc. specializes in sales and marketing, they uniquely blend management consulting and creative services to help change behaviors and deliver on your brand promise. Its passion expertise and many late nights are dedicated to this pursuit, perfecting your experience and driving results. As ambassadors for your customers experience they practice in 3 area marketing optimization, contact center effectiveness and field sales & services

Leinco Technologies, Inc. is a specialty manufacturer of early discovery research products, including antibodies, recombinant proteins, ELISA kits, and other life sciences products. Leinco Technologies is based in St. Louis, MO, and operates out of a 27,000 square foot facility with significant laboratory space to service all customer and regulatory requirements. The company also offers a full suite of custom development and manufacturing services and serves leading drug discovery and in vitro diagnostic companies around the world. The company was founded in 1992 by Patrick Leinert, who has been the CEO since then.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.

S2 Genomics, Inc. develops laboratory automation solutions for processing solid tissues for life science applications. The company was founded by Stevan Jovanovich, Peter Wagner, Shannon Hall and Roger McIntosh in 2016 and is headquartered in Livermore, CA.

Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.

The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington.

Apse, Inc. offers technology and strategy services. It develops technology that will allow the cost efficient production of RNA for broad acre topical RNAi uses in agriculture. The company was founded by Juan Arhancet in 2011 and is headquartered in St. Louis, MO.

Sigma-Aldrich Co. is a privately held life science and technology company. They produce chemical and biochemical products and kits for scientific research. The company was founded in 1934 and is headquartered in Saint Louis, MO

Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO.

Kypha, Inc. engages in the development of devices and products to monitor and treat inflammatory and autoimmune disorders. Its products include Comp act, RapiPlex, and sample stabilization. The company was founded by Paul K. Olson and Chad M. Stiening on January 14, 2011 and is headquartered in St. Louis, MO.

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Part of Incyte Corp., Genome Systems, Inc. is a company that researches and develops biotechnical products. The company is based in St. Louis, MO. The company was founded by David Adam Smoller. Genome Systems was acquired by Incyte Corp. on July 23, 1996 for $7.33 million.

Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

Thompson Street Capital Managers LLC (Thompson Street Capital) is a private equity subsidiary of Thompson Street Capital Partners LLC, founded in 2000 by James A. Cooper and Peter Finley. The firm is headquartered in St. Louis, Missouri.

BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri.

Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen.

Part of Revvity, Inc., Sage Labs, Inc. is a company that provides animal research models and support services. The company is based in St. Louis, MO. Sage Labs was acquired by Horizon Discovery Group Ltd., part of Revvity, Inc. from December 24, 2020 on September 29, 2014 for $48.05 million.